#What is Midjourney’s New Medical Initiative?
Midjourney, widely recognized for its ability to transform text prompts into stunning images, has unexpectedly ventured into the medical field. The company has introduced a new division known as Midjourney Medical along with an ambitious concept for a full-body ultrasonic scanner. This innovative device aims to revolutionize medical imaging, steering clear of traditional MRI machines that often involve radiation and claustrophobic experiences.
#How Does Midjourney's Scanner Work?
This scanner operates using sound waves and water immersion to create a comprehensive image of the human body. The proposed specifications are impressive, targeting a resolution of 0.5mm, and promising to complete a full-body scan in just 60 seconds. For comparison, the duration for a standard MRI scan in a single body region can range from 15 to 90 minutes. The resolution depends considerably on equipment quality and settings.
The technology behind this scanner includes approximately 8,960 transducers. These are essential components that send and receive sound waves to produce the images. The data transmission rate is remarkable at 17 GB per second. To put this into perspective, that rate is equivalent to downloading three full HD movies every second.
#What are the Plans for Implementation?
Midjourney has announced plans to establish a flagship location in San Francisco, aiming to house up to ten of these advanced scanners by the year 2027. Investors and industry watchers will be closely monitoring this timeline.
#Is There a Connection to Cryptocurrency?
While there have been headlines mentioning the term 'Mythos' in relation to Midjourney Medical, it is crucial to clarify the confusion. There are no verified connections between this new medical initiative and the Mythos token, a cryptocurrency linked to the Web3 gaming protocol. Official communications and reports from Midjourney do not reference blockchain technology, crypto tokens, or digital assets.
The Mythos token is part of the Mythical Games ecosystem and does not intersect with Midjourney’s medical endeavors. It is essential for investors to distinguish between speculative narratives and verified facts. Any unusual trading activity linked to Mythos following this announcement may stem from name confusion rather than any actual partnership.
#What Should Investors Take Away?
The material risks involved in hardware development are significant. Midjourney has yet to release a physical product, particularly something as complex as a Class II or Class III medical device. The future timeline for operational scanners in San Francisco is a key indicator for investors to watch. Understanding these elements can help steer investment decisions amidst a landscape prone to speculation.